1. Home
  2. IPSC vs SMID Comparison

IPSC vs SMID Comparison

Compare IPSC & SMID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IPSC
  • SMID
  • Stock Information
  • Founded
  • IPSC 2019
  • SMID 1960
  • Country
  • IPSC United States
  • SMID United States
  • Employees
  • IPSC N/A
  • SMID N/A
  • Industry
  • IPSC Medicinal Chemicals and Botanical Products
  • SMID Building Materials
  • Sector
  • IPSC Health Care
  • SMID Industrials
  • Exchange
  • IPSC Nasdaq
  • SMID Nasdaq
  • Market Cap
  • IPSC 149.1M
  • SMID 166.5M
  • IPO Year
  • IPSC 2021
  • SMID 1995
  • Fundamental
  • Price
  • IPSC $1.21
  • SMID $45.50
  • Analyst Decision
  • IPSC Strong Buy
  • SMID
  • Analyst Count
  • IPSC 4
  • SMID 0
  • Target Price
  • IPSC $13.00
  • SMID N/A
  • AVG Volume (30 Days)
  • IPSC 497.3K
  • SMID 24.7K
  • Earning Date
  • IPSC 11-05-2024
  • SMID 11-14-2024
  • Dividend Yield
  • IPSC N/A
  • SMID N/A
  • EPS Growth
  • IPSC N/A
  • SMID 1025.92
  • EPS
  • IPSC N/A
  • SMID 1.22
  • Revenue
  • IPSC $2,684,000.00
  • SMID $76,366,000.00
  • Revenue This Year
  • IPSC $244.52
  • SMID N/A
  • Revenue Next Year
  • IPSC $27.73
  • SMID N/A
  • P/E Ratio
  • IPSC N/A
  • SMID $36.88
  • Revenue Growth
  • IPSC 7.88
  • SMID 32.40
  • 52 Week Low
  • IPSC $1.14
  • SMID $25.03
  • 52 Week High
  • IPSC $5.51
  • SMID $48.87
  • Technical
  • Relative Strength Index (RSI)
  • IPSC 38.14
  • SMID 72.25
  • Support Level
  • IPSC $1.20
  • SMID $39.84
  • Resistance Level
  • IPSC $1.29
  • SMID $46.20
  • Average True Range (ATR)
  • IPSC 0.12
  • SMID 2.65
  • MACD
  • IPSC -0.01
  • SMID 0.91
  • Stochastic Oscillator
  • IPSC 2.71
  • SMID 93.24

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company specializes in leveraging adult stem cells to develop advanced cell therapy products targeting cancer, autoimmune, and inflammatory diseases. Their innovative approach involves a genetically engineered allogeneic cell therapy platform comprising induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and cutting-edge manufacturing capabilities. This comprehensive platform aims to overcome the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and minimizing development and supply risks.

About SMID Smith-Midland Corporation

Smith-Midland Corp through its subsidiaries invents, develops, manufactures, markets, sells, and installs precast concrete products for primary use in the construction, highway, utilities, and farming industries. The firm's customers are general contractors and federal, state, and local transportation authorities. Its products include Slenderwall, JJhooks, Softsound, Sierra Wall and Easi set. A substantial portion of the company's business is derived from local, state, and federal building projects. The company generates revenues predominantly from the sale, leasing, licensing, shipping, and installation of precast concrete products for the construction, utility, and farming industries.

Share on Social Networks: